Glaukos ROE 2014-2024 | GKOS

Current and historical return on equity (ROE) values for Glaukos (GKOS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Glaukos ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-03-31 $-0.14B $0.45B -30.00%
2023-12-31 $-0.14B $0.46B -27.86%
2023-09-30 $-0.13B $0.48B -25.72%
2023-06-30 $-0.13B $0.49B -24.46%
2023-03-31 $-0.14B $0.51B -26.05%
2022-12-31 $-0.10B $0.53B -17.87%
2022-09-30 $-0.09B $0.55B -15.85%
2022-06-30 $-0.06B $0.56B -9.71%
2022-03-31 $-0.03B $0.60B -4.73%
2021-12-31 $-0.05B $0.59B -8.30%
2021-09-30 $-0.04B $0.60B -6.22%
2021-06-30 $-0.06B $0.58B -9.59%
2021-03-31 $-0.08B $0.59B -12.86%
2020-12-31 $-0.12B $0.67B -18.39%
2020-09-30 $-0.07B $0.66B -11.07%
2020-06-30 $-0.07B $0.66B -13.11%
2020-03-31 $-0.04B $0.64B -8.75%
2019-12-31 $0.02B $0.67B 5.18%
2019-09-30 $-0.02B $0.19B -10.31%
2019-06-30 $-0.01B $0.19B -6.76%
2019-03-31 $-0.01B $0.19B -6.56%
2018-12-31 $-0.01B $0.17B -8.27%
2018-09-30 $-0.01B $0.16B -9.44%
2018-06-30 $-0.01B $0.15B -4.27%
2018-03-31 $-0.00B $0.14B -2.97%
2017-12-31 $0.00B $0.14B 0.00%
2017-09-30 $-0.00B $0.13B -0.80%
2017-06-30 $-0.00B $0.13B -0.84%
2017-03-31 $0.00B $0.12B 3.52%
2016-12-31 $0.00B $0.12B 3.72%
2016-09-30 $0.00B $0.11B 1.96%
2016-06-30 $-0.00B $0.11B -1.02%
2016-03-31 $-0.04B $0.10B -36.55%
2015-12-31 $-0.04B $0.10B -52.67%
2015-09-30 $-0.04B $0.10B -87.91%
2015-06-30 $-0.04B $0.10B -179.31%
2015-03-31 $-0.01B $-0.00B 450.00%
2014-12-31 $-0.01B $-0.00B 1200.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.716B $0.315B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.750B 26.63
Intuitive Surgical (ISRG) United States $151.847B 91.47
Edwards Lifesciences (EW) United States $52.890B 34.42
DexCom (DXCM) United States $46.609B 70.60
Alcon (ALC) Switzerland $45.493B 32.60
IDEXX Laboratories (IDXX) United States $42.473B 49.78
IQVIA Holdings (IQV) United States $39.621B 22.99
STERIS (STE) Ireland $22.336B 26.08
SONOVA HOLDING (SONVY) Switzerland $18.970B 0.00
Waters (WAT) United States $17.853B 26.24
Hologic (HOLX) United States $16.915B 18.92
Fresenius Medical Care AG KGaA (FMS) Germany $12.617B 14.73
Sysmex ADR (SSMXY) Japan $10.454B 32.78
Teleflex (TFX) United States $9.943B 15.48
Globus Medical (GMED) United States $8.962B 26.27
Penumbra (PEN) United States $7.434B 84.48
Masimo (MASI) United States $7.039B 40.55
TransMedics (TMDX) United States $4.673B 443.38
Integer Holdings (ITGR) United States $3.954B 23.89
PROCEPT BioRobotics (PRCT) United States $3.376B 0.00
Tandem Diabetes Care (TNDM) United States $3.058B 0.00
LivaNova (LIVN) United Kingdom $2.860B 16.98
Inari Medical (NARI) United States $2.726B 0.00
Nihon Kohden (NHNKY) Japan $2.678B 14.18
Elekta AB (EKTAY) Sweden $2.455B 18.82
Integra LifeSciences Holdings (IART) United States $2.292B 10.00
RxSight (RXST) United States $2.148B 0.00
Veracyte (VCYT) United States $1.687B 0.00
Alphatec Holdings (ATEC) United States $1.508B 0.00
Artivion (AORT) United States $0.983B 94.32
AVANOS MEDICAL, INC (AVNS) United States $0.926B 18.02
OPKO Health (OPK) United States $0.913B 0.00
Silk Road Medical (SILK) United States $0.882B 0.00
OrthoPediatrics (KIDS) United States $0.750B 0.00
Pulse Biosciences (PLSE) United States $0.738B 0.00
IRadimed (IRMD) United States $0.562B 31.47
SiBone (SIBN) United States $0.550B 0.00
Paragon 28 (FNA) United States $0.546B 0.00
Pacific Biosciences Of California (PACB) United States $0.539B 0.00
Mesa Laboratories (MLAB) United States $0.515B 15.27
ORTHOFIX MEDICAL INC (OFIX) United States $0.473B 0.00
Treace Medical Concepts (TMCI) United States $0.376B 0.00
AxoGen (AXGN) United States $0.352B 0.00
Nevro (NVRO) United States $0.347B 0.00
Sight Sciences (SGHT) United States $0.341B 0.00
Semler Scientific (SMLR) United States $0.287B 14.54
Tactile Systems Technology (TCMD) United States $0.285B 9.75
AngioDynamics (ANGO) United States $0.246B 0.00
CVRx (CVRX) United States $0.221B 0.00
908 Devices (MASS) United States $0.211B 0.00
NeuroPace (NPCE) United States $0.200B 0.00
Inogen (INGN) United States $0.199B 0.00
Delcath Systems (DCTH) United States $0.199B 0.00
EDAP TMS S.A (EDAP) France $0.196B 0.00
Accuray (ARAY) United States $0.184B 0.00
Alpha Tau Medical (DRTS) Israel $0.162B 0.00
Atossa Genetics (ATOS) United States $0.161B 0.00
ClearPoint Neuro (CLPT) United States $0.155B 0.00
Yubo Biotech (YBGJ) China $0.119B 0.00
KORU Medical Systems (KRMD) United States $0.108B 0.00
Spectral Diagnostics (EDTXF) Canada $0.102B 0.00
Sensus Healthcare (SRTS) United States $0.089B 18.79
Monogram Orthopaedics (MGRM) United States $0.067B 0.00
InspireMD (NSPR) Israel $0.065B 0.00
EnVVeno Medical (NVNO) United States $0.064B 0.00
Hyperfine (HYPR) United States $0.063B 0.00
Neuronetics (STIM) United States $0.061B 0.00
SEP Acquisition (SEPA) United States $0.058B 0.00
LENSAR (LNSR) United States $0.056B 0.00
Envoy Medical (COCH) United States $0.049B 0.00
Vicarious Surgical (RBOT) United States $0.043B 0.00
T2 Biosystems (TTOO) United States $0.042B 0.00
ReWalk Robotics (LFWD) Israel $0.040B 0.00
Lucid Diagnostics (LUCD) United States $0.039B 0.00
Precision Optics (POCI) United States $0.038B 0.00
DarioHealth (DRIO) United States $0.034B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
Autonomix Medical (AMIX) United States $0.027B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.025B 0.00
Pixie Dust Technologies (PXDT) Japan $0.025B 0.00
Aspira Women's Health (AWH) United States $0.023B 0.00
Ekso Bionics Holdings (EKSO) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Venus Concept (VERO) Canada $0.006B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00